Clinical Trials Browser

Phase 2 × Terminated × ALK-positive Non-small Cell Lung Cancer × Clear all

NCT04211922 2024-04-26

Alkotinib Capsule in Patients With ALK-positive Non-small Cell Lung Cancer Previously Treated With Crizotinib

Phase 2 Terminated

ALK-positive Non-small Cell Lung Cancer

NCT02513667 2023-02-03

Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma

Phase 2 Terminated

14 enrolled 12 charts

ALK-positive Non-small Cell Lung Cancer